Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type

general

An aggressive (fast-growing) type of T-cell non-Hodgkin lymphoma marked by enlarged lymph nodes and hypergammaglobulinemia (increased antibodies in the blood). Other symptoms may include a skin rash, fever, weight loss, or night sweats.

15

Centers

30

Active Trials

$4.3B

Cancer Funding

Specific Cancer Types(2)

NameCenters
Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type15
Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type15

Top Centers for Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type(15)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
—
2
Yale Cancer Center Yale School of MedicineNew Haven, CT
NCI Comprehensive
—
3
Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX
NCI Comprehensive
—
4
Duke Cancer InstituteDurham, NC
NCI Comprehensive
—
5
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
—
6
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
—
7
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
—
8
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
—
9
Montefiore Einstein Comprehensive Cancer CenterBronx, NY
NCI Comprehensive
—
10
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
—
11
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
—
12
University of Illinois Cancer CenterChicago, IL
—
13
Cancer Center at IllinoisUrbana, IL
—
14
Princess Margaret Cancer CentreToronto, ON
—
15
BC CancerVancouver, BC
—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →